Diffuse Intrinsic Pontine Glioma Clinical Trials
3 recruiting trials for Diffuse Intrinsic Pontine Glioma. Eligibility criteria explained in plain English.
3
Total Trials
3
Recruiting Now
0
Phase 3 Trials
3
Sponsors
Recruiting Trials
RECRUITINGNCT01106794
Molecular Analysis of Samples From Patients With Diffuse Intrinsic Pontine Glioma and Brainstem Glioma
The purpose of this study is to prospectively collect specimens from pediatric patients with diffuse intrinsic pontine glioma or brainstem glioma, either during therapy or at...
Sponsor: Children's National Research InstituteEnrolling: 1001 location
RECRUITINGPhase 1 / Phase 2NCT06465199
Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas
The purpose of this study is to evaluate the investigational oral drug AMXT 1501 in combination with oral eflornithine (DFMO). An investigational drug is one that has not been...
Sponsor: Milton S. Hershey Medical CenterEnrolling: 2896 locations
RECRUITINGPhase 1NCT04099797
C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)
In this study, there are two treatment groups called Cohort 1 and Cohort 2. Cohort 1 is for patients with diffuse midline glioma, high grade glioma, diffuse intrinsic pontine...
Sponsor: Baylor College of MedicineEnrolling: 371 location